Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is U  [Clear All Filters]
Watts AE. Use of Stem Cells for the Treatment of Musculoskeletal Injuries in Horses. Vet Clin North Am Equine Pract. 2023.
Rogers KJ, Mott SL, Parsons MG, Schlueter AJ. Use of subgroup-specific hematopoietic stem cell collection efficiencies to improve truncation calculations for large-volume leukapheresis procedures. J Clin Apher. 2023.
Hsu Y-HH, Pintacuda G, Liu R, Nacu E, Kim A, Tsafou K, Petrossian N, Crotty W, Suh JMin, Riseman J, et al. Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia. iScience. 2023;26(5):106701.
Yammine KM, Abularach SMirda, Sampurno L, Bateman JF, Lamandé SR, Shoulders MD. Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C iPSC line (MCRIi019-A-6) model of human precocious osteoarthritis. Stem Cell Res. 2023;67:103020.
Roy A, Sakthikumar S, Kozyrev SV, Nordin J, Pensch R, Mäkeläinen S, Pettersson M, Karlsson EK, Lindblad-Toh K, Forsberg-Nilsson K. Using evolutionary constraint to define novel candidate driver genes in medulloblastoma. Proc Natl Acad Sci U S A. 2023;120(33):e2300984120.
Koui Y, Kido T. Using human induced pluripotent stem cell-derived liver cells to investigate the mechanisms of liver fibrosis in vitro. Biochem Soc Trans. 2023.
Chang C-H, Chen T-Y, Tang TK. Using in vivo cerebellar electroporation to study neuronal cell proliferation and differentiation in a Joubert syndrome mouse model. Methods Cell Biol. 2023;175:235-249.
Lai J-S, Jensen SE, Peipert JDevin, Mitchell SA, Garcia SF, Cella D, Goldman S, Lenzen A. Using IT to Improve Outcomes for Children Living With Cancer (SyMon-SAYS): Protocol for a Single-Institution Waitlist Randomized Controlled Trial. JMIR Res Protoc. 2023;12:e50993.
Dupuy AMM, Juin PP, Guen VJ. Using mammary organoids to study cilia. Methods Cell Biol. 2023;175:221-233.
Dekker SE, Réa D, Cayuela J-M, Arnhardt I, Leonard J, Heuser M. Using Measurable Residual Disease to Optimize Management of AML, ALL, and Chronic Myeloid Leukemia. Am Soc Clin Oncol Educ Book. 2023;43:e390010.
Zhou AKailin, Jou E, Lu V, Zhang J, Chabra S, Abishek J, Wong E, Zeng X, Guo B. Using Pre-Clinical Studies to Explore the Potential Clinical Uses of Exosomes Secreted from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem cells. Tissue Eng Regen Med. 2023.
Ge N, Liu M, Li R, Allen NM, Galvin J, Shen S, O'Brien T, Prendiville TW. Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A). Stem Cell Rev Rep. 2023.
Ong HTing, Prêle CM, Dilley RJ. Using RNA-seq to identify suitable housekeeping genes for hypoxia studies in human adipose-derived stem cells. BMC Mol Cell Biol. 2023;24(1):16.
Risso MAparecida, Deffune E, Luzo ÂCristina M. Using umbilical cord blood as a source of paediatric packed red blood cells: Processing and quality control. Vox Sang. 2023.
Hu JC, Osborn SL, Sanchez PC, Xu W, Christiansen BA, Kurzrock EA. Using uniaxial tensile testing to evaluate the biomechanical properties of bladder tissue after spinal cord injury in rat model. J Biomech. 2023;152:111571.
Zhang H, Li X, Liu X, Ji X, Ma X, Chen J, Bao Y, Zhang Y, Xu L, Yang L, et al. The usnic acid derivative peziculone targets cell wall of Gram-positive bacteria revealed by high throughput CRISPRi-seq analysis. Int J Antimicrob Agents. 2023:106876.
Li X, Li X. USP21 Promotes the Progression of Nasopharyngeal Carcinoma by Regulating FOXM1. Stem Cells Int. 2023;2023:9196583.
Cai F, Song B, Yang Y, Liao H, Li R, Wang Z, Cao R, Chen H, Wang J, Wu Y, et al. USP25 contributes to defective neurogenesis and cognitive impairments. FASEB J. 2023;37(6):e22971.
Liu C, Sun L, Tan Y, Wang Q, Luo T, Li C, Yao N, Xie Y, Yi X, Zhu Y, et al. USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities. Sci Adv. 2023;9(20):eade3888.
Chang Y, Chen L, Tang J, Chen G, Ji J, Xu M. USP7-mediated JUND suppresses RCAN2 transcription and elevates NFATC1 to enhance stem cell property in colorectal cancer. Cell Biol Toxicol. 2023.
Courbiere B, Drikes B, Grob A, Hamidou Z, Saultier P, Bertrand Y, Gandemer V, Plantaz D, Plat G, Poiree M, et al. Uterine volume is dramatically decreased after Hematopoietic Stem Cell Transplantation during childhood regardless of the conditioning regimen. Fertil Steril. 2023.
Gleicher N, Darmon SK, Patrizio P, Barad DH. The utility of all-freeze IVF cycles depends on the composition of study populations. J Ovarian Res. 2023;16(1):190.
Krishnan RPoothakula, Pandiar D, Ramani P, Ramalingam K, Jayaraman S. Utility of CD44/CD24 in the Outcome and Prognosis of Oral Squamous Cell Carcinoma: A Systematic Review. Cureus. 2023;15(8):e42899.
Tran M, Palmer S, Moore DT, Bartelt L, Friedland A, Grgic T, Lachiewicz A, Ptachcinski J, Sena A, Trepte M, et al. Utility of Urine Cultures During Febrile Neutropenia Workup in Hematopoietic Stem Cell Transplantation Recipients Without Urinary Symptoms. Open Forum Infect Dis. 2023;10(5):ofad236.
Jain AG, Ball S, Aguirre LE, Tobon KA, Chan O, Padron E, Kuykendall A, Komrokji R, Sallman D, Lancet JE, et al. Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2023.